As experts in this emerging market, Durée & Company is well-appointed to guide your psychedelics brand. Our team will put a public relations and marketing plan in place that addresses your brand story, key audiences and viable channels for sharing your message.
We don’t sit back and wait for clients to have news. We strategize to help clients make the news.
Public Relations & Marketing
In the health and wellness marketplace, psychedelics are quickly captivating attention, from their proven results to treat the S.A.A.D epidemic (Suicide, Anxiety, Addiction and Depression) to the growing number of ketamine clinics in the U.S. Durée & Company offers services in PR and marketing for newly regulated markets, including strategic public relations support, effective marketing, innovative branding, in-depth media outreach, and the development of corporate social responsibility (CSR) initiatives.
Our proven psychedelic, psychedelic science, psychedelic-assisted therapy and psychedelic venture capital and private equity public relations outreach has placed clients in notable media outlets including The Wall Street Journal, Forbes, Fox News, Green Entrepreneur, Page Six, VICE, and more.
We understand how to navigate the growing NeuroWellness category, as we currently work in this space with several clients. With proven relationships with thought leaders, we are an established presence in this rapidly expanding community.
If you are an emerging brand in the health and wellness marketplace, you can trust Durée & Company as your public relations partner.
The psychedelics industry, as it continues to evolve, has its own unique set of opportunities.
Our team understands the need for education and anticipatory thinking. We know the guidelines the FDA and DEA have put in place and how to effectively share news about these products. Campaigns are centered around scientific data and our goal is to always put forth and maintain the transparency of our clients, while helping them navigate challenging situations.
Our philosophy is always to be proactive and help guide our clients around any potentially negative situations.
The Psychedelic Renaissance
With the NeuroWellness industry projected to reach over $6 billion by 2027, it’s important to consider an impactful communications strategy.
Psilocybin, LSD, Ketamine and other psychedelics have recently caught the attention of startups and investors as they have lucrative market potential. Scientists are revisiting hallucinogens like mushrooms and LSD as possible therapeutics for depression, addiction, PTSD, obsessive-compulsive disorder and anxiety. Psychedelic drugs have now been recast as possible solutions to a range of mental health problems.
Companies are developing medicines from psilocybin, MDMA, ibogaine and LSD, all of which are illegal in the US, as well as from ketamine, a legal anesthetic with hallucinogenic properties. With hope to treat a wide range of conditions, including post-traumatic stress disorder (PTSD), suicide, depression, anxiety, addiction, even Alzheimer’s disease, a growing body of research into the therapeutic use of psychedelics is delivering promising results.
Regardless of whether you’re an established or developing psychedelics company, Durée & Company evaluates your goals, builds the right press strategy campaign, and delivers smart messaging right into the hands of media. We understand how to hone marketing messages in highly-regulated industries.
We effectively communicate the facts surrounding your business to educate and quell the concerns of stakeholders, as well as to bring attention and awareness to your company. As a result, we are able to position our clients in a prominent fashion, fulfilling the goals established.
Not only are we hyper-focused on crafting messaging and campaigns that are compelling and resonate with target audiences, but we’re also deeply aware of how important it is to give each and every client our focused attention.
We do this by staying current on policies and innovation within the industry. We also have access to valuable resources. With our insider tips and proven relationships, we are constantly finding powerful ways to position our clients as the first choice for new customers, partners and media.
As companies seek to publicize scientific findings, solidify investment opportunities and educate the public about the many benefits of psychedelics, Durée & Company is here to serve as your communication partner, so no opportunity is left to chance.
We know how to reach audiences with strategic announcements, speaking opportunities, advertising, and meaningful partner relationships in in future-forward and emerging categories such as psychedelics and other highly-regulated industries. We also understand how to break the mold and communicate in targeted and unique ways. We specialize in creating tailored plans for each of our clients to best suit their needs.
Based in Fort Lauderdale, Florida and with an office in Aspen, Colorado, our agency works with national accounts resulting in contacts across the U.S. Our database continues to grow 24/7. Every day, we create new relationships with editors, journalists, broadcast reporters, bloggers and influencers, thus adding endless possibilities for media coverage.
With bloggers and influencers becoming increasingly more important in the PR world, our relationships extend into digital media as well. With a strong network, ranging from health and wellness to technology and agriculture, our agency can leverage relationships in order to create successful campaigns.
We don't like to brag, but we're changing the game.
“Durée & Company has been an invaluable asset since day one. Not only do they understand the emerging psychedelic space and the intricacies of launching and promoting a venture capital fund, but they’ve also provided meaningful counsel. They have put forth ideas and timelines that have helped us effectively communicate, which has positively impacted our business. We are fortunate to work with an agency that is passionate about client service and goes above and beyond what is expected. I wouldn’t be where I am without Durée!”Iter InvestmentsManaging Principal